newsfilter
← Latest News
GlobeNewswire·

Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)

WAYNE, Pa., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today